1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL C-REACTIVE PROTEIN (CRP) TESTING MARKET BY TYPE
5.1. Introduction
5.2. Immunoturbidimetric method
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. ELISA
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
5.4. Chemiluminescence
5.4.1. Market Opportunities and Trends
5.4.2. Growth Prospects
5.4.3. Geographic Lucrativeness
5.5. Spectrometry
5.5.1. Market Opportunities and Trends
5.5.2. Growth Prospects
5.5.3. Geographic Lucrativeness
6. GLOBAL C-REACTIVE PROTEIN (CRP) TESTING MARKET BY APPLICATION
6.1. Introduction
6.2. Cardiovascular Diseases
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Cancer
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
6.4. Rheumatoid Arthritis
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
6.4.3. Geographic Lucrativeness
6.5. Lupus
6.5.1. Market Opportunities and Trends
6.5.2. Growth Prospects
6.5.3. Geographic Lucrativeness
6.6. Others
6.6.1. Market Opportunities and Trends
6.6.2. Growth Prospects
6.6.3. Geographic Lucrativeness
7. GLOBAL C-REACTIVE PROTEIN (CRP) TESTING MARKET BY END USERS
7.1. Introduction
7.2. Hospitals and Clinics
7.2.1. Market Opportunities and Trends
7.2.2. Growth Prospects
7.2.3. Geographic Lucrativeness
7.3. Diagnostic Centres
7.3.1. Market Opportunities and Trends
7.3.2. Growth Prospects
7.3.3. Geographic Lucrativeness
8. GLOBAL C-REACTIVE PROTEIN (CRP) TESTING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Type
8.2.2. By Application
8.2.3. By End Users
8.2.4. By Country
8.2.4.1. United States
8.2.4.1.1. Market Opportunities and Trends
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Opportunities and Trends
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Opportunities and Trends
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Type
8.3.2. By Application
8.3.3. By End Users
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Opportunities and Trends
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Opportunities and Trends
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Opportunities and Trends
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Type
8.4.2. By Application
8.4.3. By End Users
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.1.1. Market Opportunities and Trends
8.4.4.1.2. Growth Prospects
8.4.4.2. Germany
8.4.4.2.1. Market Opportunities and Trends
8.4.4.2.2. Growth Prospects
8.4.4.3. France
8.4.4.3.1. Market Opportunities and Trends
8.4.4.3.2. Growth Prospects
8.4.4.4. Others
8.4.4.4.1. Market Opportunities and Trends
8.4.4.4.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Type
8.5.2. By Application
8.5.3. By End Users
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Opportunities and Trends
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Opportunities and Trends
8.5.4.2.2. Growth Prospects
8.5.4.3. Israel
8.5.4.3.1. Market Opportunities and Trends
8.5.4.3.2. Growth Prospects
8.5.4.4. Others
8.5.4.4.1. Market Opportunities and Trends
8.5.4.4.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Type
8.6.2. By Application
8.6.3. By End Users
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. Market Opportunities and Trends
8.6.4.1.2. Growth Prospects
8.6.4.2. India
8.6.4.2.1. Market Opportunities and Trends
8.6.4.2.2. Growth Prospects
8.6.4.3. South Korea
8.6.4.3.1. Market Opportunities and Trends
8.6.4.3.2. Growth Prospects
8.6.4.4. Taiwan
8.6.4.4.1. Market Opportunities and Trends
8.6.4.4.2. Growth Prospects
8.6.4.5. Thailand
8.6.4.5.1. Market Opportunities and Trends
8.6.4.5.2. Growth Prospects
8.6.4.6. Indonesia
8.6.4.6.1. Market Opportunities and Trends
8.6.4.6.2. Growth Prospects
8.6.4.7. Japan
8.6.4.7.1. Market Opportunities and Trends
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Opportunities and Trends
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medix Biochemica
10.2. Biolab
10.3. Abbott
10.4. Novus Biologicals, LLC
10.5. Cenogenics Corporation
10.6. Salimetrics, LLC
10.7. Randox Laboratories Ltd
10.8. Thermo Fisher Scientific
10.9. Beckman Coulter, Inc.
10.10. Trinity Biotech